title: Expenditures and Prices of Antihyperglycemic Medications in the United States: 2002-2013.
authors.affiliation: School of Population and Global Health, University of Melbourne, Victoria, Australia.
authors.forename: Xinyang
authors.initials: X
authors.lastname: Hua
authors.affiliation: School of Population and Global Health, University of Melbourne, Victoria, Australia.
authors.forename: Natalie
authors.initials: N
authors.lastname: Carvalho
authors.affiliation: School of Population and Global Health, University of Melbourne, Victoria, Australia.
authors.forename: Michelle
authors.initials: M
authors.lastname: Tew
authors.affiliation: Department of Medicine, University of Chicago, Chicago, Illinois.
authors.forename: Elbert S
authors.initials: ES
authors.lastname: Huang
authors.affiliation: School of Public Health, University of Michigan, Ann Arbor.
authors.forename: William H
authors.initials: WH
authors.lastname: Herman
authors.affiliation: School of Population and Global Health, University of Melbourne, Victoria, Australia.
authors.forename: Philip
authors.initials: P
authors.lastname: Clarke
mesh_terms: D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000453:epidemiology; D016527:Drug Costs; D005260:Female; D005382:Financing, Personal / Q000191:economics*; D005102:Health Expenditures; D006801:Humans; D007004:Hypoglycemic Agents / Q000191:economics*; D007328:Insulin / Q000031:analogs & derivatives / Q000191:economics* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D014481:United States / Q000453:epidemiology
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin